ReviewFrontiers in oncology2026
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review.
Giovanni Dima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it